1. Latest News
  2. Submit Press Release

Breakthrough Cancer Treatment Patent to Issue

Cancer Code Corporation: the dawn of a new approach to cancer treatment.

 
PRLog - Nov. 9, 2012 - ALBUQUERQUE, N.M. -- ALBUQUERQUE, NM - Cancer Code Corporation (C3) announces that U.S. Patent No. 8,315,712 will issue on November 20, 2012.   This patent, entitled “Hybrid Scientific Computer System for Processing Cancer Cell Signals as Medical Therapy” covers a breakthrough approach to cancer treatment by killing cancer cells.  

This new cancer treatment technology applies ultra-low voltage encoded cellular signals (treatment-codes) to rapidly injure a cancer's cellular electrical communication process and trigger the cancer cells’ suicide (apoptosis), while causing no adverse effects to the surrounding healthy tissue.

The technology takes advantage of the fact that malignant cancer cells communicate with one-another.  This makes it possible for treatment-codes to be transmitted from cancer cell to cancer cell, wrecking and shutting-down its cellular electrical communication process.

C3 is the licensee of the cancer treatment approach covered in four pending patent applications based on the neuro-code signaling technology of inventors Eleanor Schuler, et al. C3 currently has the exclusive rights in the United States and China for this cancer killing technology.  

Other pending U.S. patent applications are as follows:

U.S. Patent Application Serial No. 12/334,212 entitled “Method to Switch-Off Cancer Cell Electrical Communication Codes as Medical Therapy”.

U.S. Patent Application Serial No. 12/936,778 entitled “System and Method to Elicit Apoptosis in Malignant Tumor Cells for Medical Therapy”.

U.S. Patent Application Serial No. 12/812,576 entitled “Method and System for Processing Cancer Cell Electrical Signals for Medical Therapy”

This cancer killing technology has the potential to replace current chemotherapy surgery and radiation approaches and represents the dawn of an entirely new treatment approach using ultra-low voltage encoded signals to destroy cancer directly and quickly.  This new and exciting breakthrough is based on the fact that all cells communicate, including cancer cells.  This approach will “signal” the cancer cells to kill themselves.

About Cancer-Code Corporation

C3, located in Albuquerque, NM, is focusing on the development and testing of cancer treatment technology that takes advantage of the fact that all cells have an electrical process and adjacent cells communicate with one another.  The approach of C3 is geared toward disrupting this cancer cell communication and “wrecking" cancer cell communication network through tiny ultra-low voltage pico-sparks defined as “Codes-of-Death” to disrupt this cancer cell communication network.  C3’s initial focus is the development of Neuro-signaling communication between cancer cells and then modifying their communication signals to disrupt communication to those malignant cancer cells. This offers a unique treatment modality that is expected not to disturb normal adjacent structures and cells.  It is this Neuro-signaling disrupting cancer cell communication that C3 intends to affect and cause rapid cancer cell apoptosis.

Additional information about C3 can be found at:

www.cancercodecorp.com

Forward-Looking Statements


To the extent any statements made in this release contain information that is not historical, these statements are essentially forward-looking and are subject to risks and uncertainties, including the difficulty of predicting FDA approvals, acceptance and demand for products flowing out of C3’s approach, the impact of competitive products and pricing, new product development and launch, reliance on key strategic alliances, availability of raw materials, availability of additional intellectual property rights, availability of future financing sources, the regulatory environment and other risks the Company may identify from time to time in the future.

Contact

Cancer Code Corporation

117 Bryn Mawr Dr S.E.

Albuquerque, NM 87106

Tel. (505) 314-1300

E-mail: cancercode1@gmail.com

--- End ---

Click to Share

Contact Email:
***@gmail.com Email Verified
Source:Cancer Code Corporation
Zip:87106
Location:Albuquerque - New Mexico - United States
Industry:Technology, Health
Tags:cancer, cancer treatment, cancer cell, cancer code, chemotherapy
Shortcut:prlog.org/12020071
Verified Account Email Address
Verified Account Phone Number

Disclaimer:   Issuers of the press releases are solely responsible for the content of their press releases. PRLog can't be held liable for the content posted by others.   Report Abuse

Latest Press Releases By “

More...

Trending News...



Like PRLog?
9K2K1K
Click to Share